07.06.2022 | COVID-19 | Letter
Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists
Erschienen in: Intensive Care Medicine | Ausgabe 7/2022
Einloggen, um Zugang zu erhalten